Mitral regurgitation: has another magic bullet bitten the dust?
作者信息
Borer Jeffrey S
出版信息
Circ Heart Fail. 2013 Jul;6(4):624-6. doi: 10.1161/CIRCHEARTFAILURE.113.000409.
Abstract
摘要
相似文献
1
Mitral regurgitation: has another magic bullet bitten the dust?二尖瓣反流：又一种神奇疗法失败了吗？
Circ Heart Fail. 2013 Jul;6(4):624-6. doi: 10.1161/CIRCHEARTFAILURE.113.000409.
2
Effects of early, late, and long-term nonselective β-blockade on left ventricular remodeling, function, and survival in chronic organic mitral regurgitation.早期、晚期和长期非选择性β受体阻滞剂对慢性器质性二尖瓣反流患者左心室重构、功能和生存的影响。
Circ Heart Fail. 2013 Jul;6(4):756-62. doi: 10.1161/CIRCHEARTFAILURE.112.000196. Epub 2013 Apr 11.
3
The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter.基线左心室大小和二尖瓣反流对卡维地洛治疗后左心室逆向重构的影响：大小并非关键因素。
Heart. 2004 Jul;90(7):800-1. doi: 10.1136/hrt.2002.009696.
4
Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.慢性心力衰竭中的β受体阻滞剂治疗：卡维地洛改善舒张功能和二尖瓣反流
Am Heart J. 2000 Apr;139(4):596-608. doi: 10.1016/s0002-8703(00)90036-x.
5
Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.卡维地洛治疗对左心室收缩功能障碍所致心力衰竭患者功能性二尖瓣反流、心室重构及收缩性的影响。
Transplant Proc. 2002 Feb;34(1):177-8. doi: 10.1016/s0041-1345(01)02717-8.
6
7
beta-blocker improvement in diastolic performance: the yin and yang of ventricular function changes.β受体阻滞剂对舒张功能的改善：心室功能变化的阴阳两面
Am Heart J. 2000 Apr;139(4):584-6. doi: 10.1016/s0002-8703(00)90034-6.
8
Beta-blocker treatment before high-risk cardiac surgery.
J Heart Lung Transplant. 2003 Mar;22(3):361-2. doi: 10.1016/s1053-2498(02)00397-2.
9
Carvedilol.卡维地洛
Arch Fam Med. 1999 Jul-Aug;8(4):295. doi: 10.1001/archfami.8.4.295.
10
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Am J Cardiol. 1997 Apr 1;79(7):1001.
引用本文的文献
1
Is there a role for combination anti-remodelling therapy for heart failure secondary to chronic rheumatic mitral regurgitation?对于慢性风湿性二尖瓣反流继发的心力衰竭，联合抗重塑治疗是否有作用？
Cardiovasc J Afr. 2017 Sep/Oct;28(5):280-284. doi: 10.5830/CVJA-2016-095.
2
Mitral valve disease--morphology and mechanisms.二尖瓣疾病——形态学与发病机制
Nat Rev Cardiol. 2015 Dec;12(12):689-710. doi: 10.1038/nrcardio.2015.161. Epub 2015 Oct 20.
3
Drug Therapy for Heart Valve Diseases.心脏瓣膜疾病的药物治疗
Circulation. 2015 Sep 15;132(11):1038-45. doi: 10.1161/CIRCULATIONAHA.115.016006.
本文引用的文献
1
Effects of early, late, and long-term nonselective β-blockade on left ventricular remodeling, function, and survival in chronic organic mitral regurgitation.早期、晚期和长期非选择性β受体阻滞剂对慢性器质性二尖瓣反流患者左心室重构、功能和生存的影响。
Circ Heart Fail. 2013 Jul;6(4):756-62. doi: 10.1161/CIRCHEARTFAILURE.112.000196. Epub 2013 Apr 11.
2
A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation.β1-受体阻滞剂治疗慢性退行性二尖瓣关闭不全的随机对照 IIb 期试验
J Am Coll Cardiol. 2012 Aug 28;60(9):833-8. doi: 10.1016/j.jacc.2012.04.029. Epub 2012 Jul 18.
3
Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.评估β受体阻滞剂对退行性二尖瓣疾病患者二尖瓣反流容积及左心室做功影响的初步研究。
Circulation. 2008 Sep 2;118(10):1041-6. doi: 10.1161/CIRCULATIONAHA.108.770438. Epub 2008 Aug 25.
4
Effect of Beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction.β受体阻滞剂治疗对重度二尖瓣反流且左心室射血分数正常患者生存率的影响。
Am J Cardiol. 2008 Sep 1;102(5):611-5. doi: 10.1016/j.amjcard.2008.04.029. Epub 2008 Jun 17.
5
Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.交感神经激活导致犬单纯二尖瓣反流所致早期代偿性容量超负荷时的黏着斑信号改变。
Circ Res. 2008 May 9;102(9):1127-36. doi: 10.1161/CIRCRESAHA.107.163642. Epub 2008 Mar 20.
6
Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.长期β受体阻滞剂在实验性慢性主动脉瓣反流中的益处。
Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1888-95. doi: 10.1152/ajpheart.01286.2007. Epub 2008 Feb 22.
7
Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease.依那普利对二尖瓣脱垂或风湿性心脏病继发反流的无症状或轻度症状患者左心室直径和运动能力的影响。
Am J Cardiol. 2005 Jul 1;96(1):117-21. doi: 10.1016/j.amjcard.2005.02.056.
8
Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation.与对照组相比，二尖瓣反流患者的全身交感神经系统被激活。
Am Heart J. 2003 Jun;145(6):1078-85. doi: 10.1016/S0002-8703(03)00111-X.
9
Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.血管紧张素转换酶抑制剂赖诺普利与β-肾上腺素能受体阻滞剂阿替洛尔对实验性二尖瓣反流血流动力学及左心室收缩功能的不同影响。
J Am Coll Cardiol. 2002 Jul 3;40(1):149-54. doi: 10.1016/s0735-1097(02)01926-5.
10
Emerging biology of mitral regurgitation: implications for further therapy.二尖瓣反流的新兴生物学：对进一步治疗的启示。
Adv Cardiol. 2002;39:15-24. doi: 10.1159/000058904.
Zotero 插件